Tff Pharmaceuticals Inc

NASDAQ:TFFP   3:59:19 PM EDT
9.81
-0.35 (-3.44%)
Products

GreenLight Biosciences Announces Feasibility Arrangement For Shelf-Stable Powder Form Of mRNA Covid-19 Vaccine Candidate

Published: 03/09/2021 13:27 GMT
Tff Pharmaceuticals Inc (TFFP) - Feasibility Arrangement for Shelf-stable Powder Form of Messenger Rna Covid-19 Vaccine Candidate Announced by Greenlight Biosciences and Tff Pharmaceuticals.
Greenlight Biosciences- Delivering Covid-19 Messenger Rna Product Candidate Materials to Tff to Perform Feasibility Formulation Work, Testing.
Greenlight Biosciences - Tff Has Two Candidates in Phase One Clinical Trials, Voriconazole Inhalation Powder and Tac-lac Inhalation Powder.
Greenlight Biosciences - Should Study Prove Successful, Next Phase May Include Non-needle Administration of Mrna Vaccines.